Therapeutic drug monitoring for lisinopril in rats using dried blood spots | [Pakistan Journal of Pharmaceutical Sciences • 2023]

Author(s):

1. Bushra T AlQuadeib: Department of Pharmaceutics, College of Pharmacy, King Saud University,Saudi Arabia, Riyadh,Saudi Arabia

2. Iman M Alfagih: Department of Pharmaceutics, College of Pharmacy, King Saud University,Saudi Arabia, Riyadh,Saudi Arabia

3. Basmah Aldosari: Department of Pharmaceutics, College of Pharmacy, King Saud University,Saudi Arabia, Riyadh,Saudi Arabia

4. Alanood Almurshedi: Department of Pharmaceutics, College of Pharmacy, King Saud University,Saudi Arabia, Riyadh,Saudi Arabia

Abstract:

A unique, easy, precise and exact high-performance liquid chromatographic-mass tandem (LCMS/MS) approach was created and validated for the measurement of the antihypertensive medicine Lisinopril (LIS) in dried blood spots (DBS). This was the first time according to our knowledge that LIS is being validated in DBS. Liquid chromatography mass tandem was utilized using the Water Acquity column as UPLC -HSS T3® column. Ten millimole ammonium formate, 0.2 percent formic acid, 0.2 percent trimethylamine, one percent acetonitrile (pH 3.0± 0.02) used as mobile phase (A), and a mobile phase (B) consisting of 0.2 percent formic acid in acetonitrile. The mobile phase lasts for 2.5 minutes at a flow rate of 0.2 ml/min. For the drug as well internal standard, the retention times (RT) obtained under optimal circumstances were 0.63±0.02 and 2.18±0.03 min, dried blood spot samples, offering consistent and quantitative drug recovery. The process was the shortest RT reported for the LIS, it is a linear relationship with concentrations from 10 - to 100ng/ml. A protein precipitation approach was used to measure the LIS. The method used to analyze DBS samples from rats receiving LIS.

Page(s): 1017-1024

DOI: 10.36721/PJPS.2023.36.3.SP.1017-1024.1

Published: Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S3, Year: 2023

Keywords:

UPLCMSMS , Validation , Lisinopril , dried blood spot

References:

[1] Agency EM .2009 .Guideline on bioanalytical method validation. , : .

[2] Araujo P .2009 .Key aspects of analytical method validation and linearity evaluation. J. Chromatogr. B, 877(23) : 2224-2234.

[3] Bernieh D .2017 .Application of microsampling methods to cardiovascular medication adherence assessment. Ph.D. Thesis, : 1-303.

[4] Bernieh D,Lawson G,Tanna S G .2017 .Quantitative LC-HRMS determination of selected cardiovascular drugs, in dried blood spots, as an indicator of adherence to medication. J. Pharm. Biomed. Anal., 142(8) : 232-243.

[5] Bicket DP .2002 .Using ACE inhibitors appropriately. Am. Fam. Physician, 66(3) : 461-469.

[6] Chernonosov A .2018 .The Use of dried blood spots for the quantification of antihypertensive drugs. Int. J. Anal. Chem, : 1-12.

[7] El-Leithy E,El-Fiky G,Nabil M .2017 .Characterization of degradation products resulted from acidic hydrolysis of lisinopril under drastic conditions. J. Adv. Pharm. Res., 1(4) : 201-208.

[8] El Bcheraoui C,Memish ZA,Tuffaha M,Daoud F,Robinson M,Jaber S,Mikhitarian S,Al Saeedi M,Almazroa MA,Mokdad AH .2014 .Hypertension and its associated risk factors in the Kingdom of Saudi Arabia, 2013: A national survey. Int. J. Hypertens, 8 : 1-9.

[9] Enderle Y,Foerster K,Burhenne J .2016 .Clinical feasibility of dried blood spots: Analytics, validation, and applications. J. Pharm. Biomed. Anal., 130(10) : 231-243.

[10] Firke SD,Bhoi KR,Patil KR,Jayswal SD,Tekade AR,Chalikwar SS .2020 .A state-of-the-art review on applications of different analytical techniques for some ace inhibitors. Anal. Chem, 10(2) : 60-79.

[11] Guideline IHT .1994 .Text on validation of analytical procedures. , : 1-5.

[12] Hussein RF,Alvi SN,Hammami MM .2019 .Rapid determination of lisinopril level in human plasma by LC-MS/MS. Acta Sci. Med, 3(9) : 3-8.

[13] Jacobs C,Kunz M,Wagmann L,Mahfoud F .2022 .Adherence monitoring of antihypertensive drugs in finger prick blood microsamples-Development and validation of an analytical procedure. Toxicol. Anal. Clin., 34(3) : S41-S48.

[14] Jacobs CM,Kunz M,Mahfoud F,Meyer MR .2023 .Closing the gap development of an analytical methodology using volumetric absorptive microsampling of finger prick blood followed by LCHRMS/MS for adherence monitoring of antihypertensive drugs. Anal. Bioanal. Chem, 415(1) : 167-177.

[15] Jarari N,Rao N,Peela JR,Ellafi KA,Shakila S,Said AR,Nelapalli NK,Min Y,Tun KD,Jamallulail SI .2015 .A review on prescribing patterns of antihypertensive drugs. Clin. Hypertens, 22(1) : 1-8.

[16] Khan MFS,Tahir L,Zhou X,Bary G,Sajid M,Shahzad AK,Khan I,Mohamed A,Ahmad R .2023 .Method development for simultaneous estimation of Amlodipine Besylate and Perindopril Tertbutyl amine in fixed-dose. Heliyon, 9 : .

[17] Kousoulos C,Tsatsou G,Dotsikas Y,Loukas YL Y .2005 .Development of a rapid liquid chromatography tandem mass spectrometry method for the determination of lisinopril, applicable for a bioequivalence study, employing a 96-well format solid phase extraction protocol. Anal. Chim. Acta, 551(1-2) : 177-183.

[18] Kronish IM,Ye S IM .2013 .Adherence to cardiovascular medications: lessons learned and future directions. Prog. Cardiovasc. Dis., 55(6) : 590-600.

[19] Li T,Liu YP,Liu SQ,Shi P,Jiang X,Tao Y,Gao XM,Ma YP,Cao Y .2022 .Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditions. BMC Pharmacol, 23(45) : 1-11.

[20] Matuszewski B,Constanzer M,Chavez-Eng C .1998 .Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem, 70(5) : 882-889.

[21] Voswinkel Meeters R.,S. Meeters R. .2018 .Bioanalytical method development and validation: from the USFDA 2001 to the USFDA 2018 guidance for industry. J. Appl. Bioanal, 4 : 67-73.

[22] Organization WH .2002 .The world health report 2002: reducing risks, promoting healthy life. , : 1-250.

[23] Qin F,Wang D,Yang S,Jing L,Xiong Z,Li F Z .2012 .Quantitative determination of lisinopril in human plasma by high performance liquid chromatography tandem mass spectrometry and its application in a pharmacokinetic study. Biomed, 26(6) : 691-696.

[24] Shah JV,Shah PA,Shah PV,Sanyal M,Shrivastav PS M .2017 .Fast and sensitive LC-MS/MS method for the simultaneous determination of lisinopril and hydrochlorothiazide in human plasma. J. Pharm. Anal., 7(3) : 163-169.

[25] Swaisland A .1991 .The pharmacokinetics of coadministered lisinopril and hydrochlorothiazide. J. Hum. Hypertens, 5(2S) : 69-71.

[26] Tanna S,Alalaqi A,Bernieh D,Lawson G .2018 .Volumetric absorptive microsampling (VAMS) coupled with high-resolution, accurate-mass (HRAM) mass spectrometry as a simplified alternative to dried blood spot (DBS) analysis for therapeutic drug monitoring of cardiovascular drugs. Clin. Mass Spectrom, 10(12) : 1-8.

[27] Vlase L,Popa DS,Muntean D,Achim M,Babes-Bol M .2010 .A new LC/MS/MS method for determination of lisinopril in human plasma. , 55(1) : 91-101.

[28] Yancy CW,Jessup M,Bozkurt B,Butler J,Casey DE,Drazner MH,Fonarow GC,Geraci SA,Horwich T,Januzzi JL .2013 .AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol., 62(3) : e147-e239.

[29] Zhou N,Liang YZ,Chen BM,Wang P,Chen X,Liu FP .2008 .Development and validation of LC-MS method for the determination of lisinopril in human plasma and its application in a bioequivalence study. J. Chromatogr. Sci., 46(1) : 848-853.

Citations

Downloads

Views